Collagenase-sensitive peptidyl-nitrogen mustards as potential antitumor agents

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Oncology

Background:

• Developing targeted cancer therapies remains a significant challenge.
• Nitrogen mustards are potent cytotoxic agents but lack tumor specificity.
• Collagenase enzymes are upregulated in certain tumors, presenting a potential targeting mechanism.

Purpose of the Study:

• To synthesize and evaluate a novel collagenase-cleavable nitrogen mustard prodrug.
• To assess the in vitro and in vivo efficacy of the designed agent against collagenase-producing tumors.

Main Methods:

• Synthesis of a Cbz-protected peptide conjugated to a nitrogen mustard moiety (Compound 10).
• In vitro enzymatic cleavage assays using bacterial and tumor-associated collagenases.
• In vivo antitumor activity testing of Compound 10 against Sarcoma-180 in animal models.

Main Results:

• Compound 10 was successfully synthesized and shown to be cleaved by collagenases at the target peptide bond.
• The cleaved product, Gly-L-Pro-Gly-NHC6H4N(CH2CH2Cl)2, exhibited over six-fold higher molar toxicity than the parent compound in vitro.
• In vivo administration of Compound 10 against Sarcoma-180 demonstrated disappointing antitumor efficacy.

Conclusions:

• The designed collagenase-cleavable nitrogen mustard agent shows promise for targeted drug delivery based on in vitro results.
• Non-specific cleavage by collagenases in normal tissues likely contributed to the lack of specific antitumor activity in vivo.
• Further optimization is needed to enhance tumor-specific activation and minimize off-target effects for effective cancer chemotherapy.